We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
C4x Discovery Holdings Plc | LSE:C4XD | London | Ordinary Share | GB00BQQ2RV18 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 12.00 | 10.30 | 10.80 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
26/3/2020 08:02 | I wonder - if the next INDV payment is due or there is a COPD deal with a US company, might any announcements be made when the US market opens? | alloa2003 | |
26/3/2020 06:46 | Looks like news is imminent to me - if it has leaked and it is signed off then they will be under pressure to announce it asap. | alloa2003 | |
25/3/2020 15:08 | INDV strength is interesting. I would go so far as to suggest a large part of their future value and defence in their DoJ lawsuit will be 'hey we're the good guys working on non-narcotic solutions to the opioid crisis' In that case they could put some serious PR behind any upcoming announcement. | the stigologist | |
25/3/2020 14:29 | Looking at INDV's share performance recently would certainly indicate something is afoot | f3rdinand | |
25/3/2020 14:27 | Not just rumours here. We know INDV have released news on the partnership molecule which C4XD haven't The next news likely on it from INDV is confirmation of entry into/start of clinical trials. This will presumably be a 'Development Milestone' which might mean a further payment to C4XD (They've received $10m of the potential $294m so far) | the stigologist | |
25/3/2020 13:14 | Just over 40ish is my break even | alloa2003 | |
25/3/2020 13:08 | If it's a 200 million pound plus deal with at least 10 million up front then they'll be selling at over 50p so not too worried! I suspect the IL 17 deal will be completed very quickly once in a position to do so as- by all accounts- it sounds like companies are fighting over it! Total bargain here below 40p imho | f3rdinand | |
25/3/2020 13:03 | There is a lot of chatter on Twitter and one tweet about this was taken down. If the news has leaked they will need to announce asap if it is in the bag. Downside, in this market there are a lot of stale bulls out there who will sell into any strength. | alloa2003 | |
25/3/2020 12:54 | Looks like it, yesterday was early leak today word getting out? Interesting afternoon ahead | zen12 | |
25/3/2020 12:52 | Undervalued as it is....but do love a rumour. No smoke without fire....let's see. | mcrudden | |
25/3/2020 12:43 | Rumours COPD deal on the way :) | alloa2003 | |
25/3/2020 12:42 | Only 75p to my break even ): | toffeeman | |
25/3/2020 12:38 | That tweet has been removed - what did it say? | alloa2003 | |
24/3/2020 22:11 | https://twitter.com/ | naim96aim | |
24/3/2020 21:37 | Hmm interesting. I need a lower target entry. Will keep an eye on this. | albert arthur | |
24/3/2020 20:57 | Just a refresher for some | the stigologist | |
24/3/2020 19:15 | How much of an idiot am I ? Been in this a while but didn't put 2+2 together to make 22 ? Their NRF programme targets COPD. COPD sufferers are a major group affected by Coronavirus. C4XD highlighted their partner LifeARC starting a £10m fund to develop COVID19 countermeasures. Quite clearly C4XD will be well placed to partake. Now with the shifting of major Government + NHS + Big Pharma resources to tackling COVID19 we could/should see major developments on the NRF front. Newsflow must be imminent. | the stigologist | |
24/3/2020 15:27 | Being quoted full ask for £500 worth?! | shrewdmole | |
24/3/2020 15:21 | Definitely something bubbling here. Last few days it’s bucked the markets and usually pm rises.... | shrewdmole | |
24/3/2020 14:26 | Could/should be 3 elements of news due Orexin/Indivior progress. INDV highlighted some progress C4XD haven't bothered mentioning it. NRF licensing Maybe leftfield - Lifearc funding for COVID19 work? | the stigologist | |
24/3/2020 11:36 | Saw some tweets on this company last few days - surprised there is little interest here as having done some research this has the potential to be absolutely huge? | reks | |
24/3/2020 10:46 | Clearly made someone consider their position and life choices | the stigologist |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions